ZP
ALXO icon

Zimmer Partners’s ALX Oncology ALXO Stock Holding History

Zimmer Partners’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,000
Closed -$377K – 123
2020
Q3 		$377K Buy
+10,000
New +$393K 0.01% 112

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Zimmer Partners's ALXO Position: Q4 2020 in Review

Zimmer Partners sold out of ALX Oncology (ALXO) in Q4 2020, closing a stake of 10,000 shares — an estimated $377K sold.

Zimmer Partners first reported a position in ALXO in Q3 2020 and held it in 1 quarter. The position peaked at $377K in Q3 2020. 89 funds tracked by Wall St. Rank hold ALXO as of Q4 2020.

  • Zimmer Partners reported no remaining ALX Oncology position as of Q4 2020 after selling out during the quarter.
  • Zimmer Partners sold 10,000 ALX Oncology shares in Q4 2020, an estimated $377K.
  • Zimmer Partners first reported a position in ALX Oncology in Q3 2020 and held it in 1 quarter.
  • Zimmer Partners's ALX Oncology position peaked at $377K in Q3 2020.
  • 89 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2020.

Based on Zimmer Partners's 13F filing for Q4 2020, filed 16 Feb 2021.